How weight-loss drugs trounced a luxury giant, explained

Last week, Danish pharma major Novo Nordisk dethroned French luxury giant LVMH to emerge as Europe’s most valued company. The secret? Humanity’s insatiable appetite for two weight-loss drugs, Ozempic and Wegovy. Mint explains the obesity crisis the world is facing.

Related Keywords

India ,United Kingdom ,Eli Lilly Mounjaro ,United Kingdom National Health Service ,Novo Nordisk ,Mohan Diabetes Specialities Centre ,World Health Organization ,Indian Council Of Medical Research ,National Health Service ,Eli Lilly ,Indian Council ,Diabetes Specialities ,Ozempic ,Wegovy ,Weight Loss ,Diabetes ,Drug ,Diabetes Drug ,Weight Loss Dru ,Lvmh ,Odemark ,Pharma ,Danish Pharma ,French Luxury ,Luxury ,